Clinical trial
Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDL
NCT00300365 · University of Pennsylvania, Other · Completed
Key facts
| NCT number | NCT00300365 |
|---|---|
| Title | Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDL |
| Official title | A Randomized, Double Blind, Placebo Controlled Trial of Pioglitazone and Niacin Extended Release in Non-diabetic Patients With Metabolic Syndrome |
| Lead sponsor | University of Pennsylvania, Other |
| Collaborators | Kos Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Metabolic Syndrome |
| Intervention type | Drug, Other |
| Interventions | Pioglitazone, Placebo, Niacin ER, Aspirin |
| Enrollment | 38 |
| Start date | Nov 1, 2005 |
| Primary completion | Aug 1, 2010 |
| Completion | Aug 1, 2010 |
| First posted | Mar 8, 2006 |
| Last update posted | Jul 28, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: